Daniel Arias
Stock Analyst at Stifel Nicolaus
(4.46)
# 1,162
Out of 4,673 analysts
516
Total ratings
50.6%
Success rate
10.4%
Average return
Main Sectors:
Stocks Rated by Daniel Arias
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MXCT MaxCyte | Maintained: Buy | $4 | $1.38 | +189.86% | 17 | Aug 13, 2026 | |
| MASS 908 Devices | Maintained: Buy | $10 → $12 | $10.68 | +12.36% | 17 | Aug 12, 2026 | |
| QGEN Qiagen | Maintained: Hold | $40 | $44.07 | -9.24% | 21 | Aug 11, 2026 | |
| TXG 10x Genomics | Maintained: Buy | $50 | $65.12 | -23.22% | 26 | Aug 11, 2026 | |
| MRVI Maravai LifeSciences Holdings | Maintained: Buy | $6 → $8 | $8.64 | -7.41% | 25 | Aug 11, 2026 | |
| ALMR Alamar Biosciences | Maintained: Buy | $28 → $32 | $34.24 | -6.54% | 3 | Aug 11, 2026 | |
| RPID Rapid Micro Biosystems | Maintained: Buy | $8 | $1.68 | +376.19% | 7 | Aug 10, 2026 | |
| BLLN BillionToOne | Maintained: Buy | $145 | $95.03 | +52.58% | 4 | Aug 6, 2026 | |
| BRKR Bruker | Maintained: Hold | $45 → $50 | $59.56 | -16.05% | 24 | Aug 5, 2026 | |
| RVTY Revvity | Rated: Hold | $100 → $110 | $124.75 | -11.82% | 29 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $600 → $650 | $629.27 | +3.29% | 33 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $380 → $420 | $410.70 | +2.26% | 29 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $225 | $219.40 | +2.55% | 49 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1,400 → $1,600 | $1,395.25 | +14.67% | 30 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $130 → $180 | $170.69 | +5.45% | 18 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $60 → $50 | $72.69 | -31.21% | 12 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $8 → $15 | $14.46 | +3.73% | 19 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $207 | $181.13 | +14.28% | 32 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $260 → $220 | $218.85 | +0.53% | 27 | Jul 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $170 | $159.00 | +6.92% | 26 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $65 → $50 | $72.32 | -30.86% | 28 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $1.67 | +199.40% | 18 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $9.55 | n/a | 9 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $2.71 | n/a | 13 | Mar 1, 2024 |
MaxCyte
Aug 13, 2026
Maintained: Buy
Price Target: $4
Current: $1.38
Upside: +189.86%
908 Devices
Aug 12, 2026
Maintained: Buy
Price Target: $10 → $12
Current: $10.68
Upside: +12.36%
Qiagen
Aug 11, 2026
Maintained: Hold
Price Target: $40
Current: $44.07
Upside: -9.24%
10x Genomics
Aug 11, 2026
Maintained: Buy
Price Target: $50
Current: $65.12
Upside: -23.22%
Maravai LifeSciences Holdings
Aug 11, 2026
Maintained: Buy
Price Target: $6 → $8
Current: $8.64
Upside: -7.41%
Alamar Biosciences
Aug 11, 2026
Maintained: Buy
Price Target: $28 → $32
Current: $34.24
Upside: -6.54%
Rapid Micro Biosystems
Aug 10, 2026
Maintained: Buy
Price Target: $8
Current: $1.68
Upside: +376.19%
BillionToOne
Aug 6, 2026
Maintained: Buy
Price Target: $145
Current: $95.03
Upside: +52.58%
Bruker
Aug 5, 2026
Maintained: Hold
Price Target: $45 → $50
Current: $59.56
Upside: -16.05%
Revvity
Aug 5, 2026
Rated: Hold
Price Target: $100 → $110
Current: $124.75
Upside: -11.82%
Aug 5, 2026
Rated: Buy
Price Target: $600 → $650
Current: $629.27
Upside: +3.29%
Aug 5, 2026
Rated: Hold
Price Target: $380 → $420
Current: $410.70
Upside: +2.26%
Aug 4, 2026
Maintained: Buy
Price Target: $225
Current: $219.40
Upside: +2.55%
Aug 3, 2026
Reiterated: Buy
Price Target: $1,400 → $1,600
Current: $1,395.25
Upside: +14.67%
Aug 3, 2026
Maintained: Buy
Price Target: $130 → $180
Current: $170.69
Upside: +5.45%
Aug 3, 2026
Maintained: Hold
Price Target: $60 → $50
Current: $72.69
Upside: -31.21%
Jul 30, 2026
Rated: Hold
Price Target: $8 → $15
Current: $14.46
Upside: +3.73%
Jul 29, 2026
Maintained: Buy
Price Target: $207
Current: $181.13
Upside: +14.28%
Jul 22, 2026
Maintained: Buy
Price Target: $260 → $220
Current: $218.85
Upside: +0.53%
May 28, 2026
Maintained: Buy
Price Target: $170
Current: $159.00
Upside: +6.92%
May 7, 2026
Maintained: Hold
Price Target: $65 → $50
Current: $72.32
Upside: -30.86%
Nov 10, 2025
Maintained: Buy
Price Target: $5
Current: $1.67
Upside: +199.40%
Jan 22, 2025
Rated: Hold
Price Target: n/a
Current: $9.55
Upside: n/a
Mar 1, 2024
Maintained: Buy
Price Target: $5
Current: $2.71
Upside: n/a